Medicine and Dentistry
Heart Failure
100%
Patient
75%
Biological Marker
48%
Diagnosis
45%
Child
32%
Systematic Review
25%
Therapeutic Procedure
24%
Cardiovascular Disease
23%
Combination Therapy
23%
Heart
22%
Heart Ventricle Remodeling
22%
Natriuretic Factor
20%
Diseases
19%
Brain Natriuretic Peptide
19%
Screening
18%
Assessment
17%
Heart Failure with Preserved Ejection Fraction
16%
Development
16%
Hypertension
16%
Diabetes
15%
Association
15%
Cardiovascular System
14%
Inpatient
14%
Fibroblast
13%
Diastolic Dysfunction
13%
Oncology
13%
e-Health
12%
Primary Health Care
12%
Cardiac Fibrosis
12%
Cells
11%
Cohort Analysis
11%
Analysis
11%
Cardiomyocyte
11%
Cardiotoxicity
10%
Epigenomics
10%
Health Care Cost
10%
Heart Ventricle Function
10%
Follow up
9%
Family
9%
Bladder Cancer
9%
Fk 506 Binding Protein
9%
Meta-Analysis
9%
Ejection Fraction
9%
Age
9%
Pathogenesis
9%
Atrial Fibrillation
9%
Malignant Neoplasm
8%
Mortality
8%
Extracellular Matrix
8%
Endothelial Cell
8%
Biochemistry, Genetics and Molecular Biology
Natriuretic Peptide
43%
Epigenetics
28%
DNA Methylation
26%
Fibroblast
20%
Development
20%
Collagen
19%
Phenotype
15%
Protein
14%
Brain Natriuretic Peptide
12%
Heart Ejection Fraction
11%
Epigenetic Modification
11%
Gene Expression
10%
Nested Gene
8%
Methylation
8%
Age
7%
Association
7%
Actin
7%
Histone Modification
7%
Wound Healing
7%
MicroRNA
6%
Epirubicin
6%
Trastuzumab
6%
RNA
5%
Myofibroblast
5%
Pharmacology, Toxicology and Pharmaceutical Science
Heart Failure
32%
Diseases
19%
Biological Marker
18%
Malignant Neoplasm
16%
Cardiotoxicity
12%
Brain Natriuretic Peptide
10%
Fibrosis
10%
Hypertension
10%
Collagen
9%
Cardiovascular Disease
9%
DNA
8%
Animal
8%
Protein
7%
Heart Muscle Fibrosis
7%
Heart Ventricle Remodeling
7%
Inflammation
7%
Natriuretic Factor
7%
Mortality
6%
Bladder Cancer
6%
Epirubicin
6%
Trastuzumab
6%
Statin (Protein)
6%
Azacitidine
6%
Breast Cancer
6%
Chemotherapy
5%
Peptide
5%
Pathogenesis
5%
Atorvastatin
5%